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m-MethoxyBA; 0.25 mM in pH 7.4 phosphate buffer and methanol (1:1) 
Excitation wavelength: 365 nm; Emission wavelength: 448 nm; Slit width 2.5 nm 
for excitation and emission, using a high sensitivity. 
Sensing Mechanism 
Conclusions 
Both BA sensors presented here have demonstrated a decrease in fluorescence intensity on increased glucose concentrations. Although m-MethoxyBA has shown the 
highest fluorescence intensity, o-COOHBA has demonstrated the ability to sense glucose in the micromolar concentrations correlating to the ocular glucose range in 
diabetic patients, 0.5-5mM. The higher excitation wavelength of 380 nm is also advantageous, as it lies close towards the visible-region of the electromagnetic spectrum, 
which allows for the use of cheap, readily available LEDs as excitation sources. Moreover, the carboxylic acid substituent of m-COOHBA is desirable for immobilizing the 
BA sensor on to various polymer substrates. 
The authors would like to thank Science Foundation Ireland (SFI) for financial support 
under the Insight Centre for Data Analytics Initiative, grant number SFI/12/RC/2289. 
o-COOHBA; 0.5 mM in pH 7.4 phosphate buffer 
Excitation wavelength 380 nm; Emission wavelength: 485 nm; Slit width 5 nm 
for excitation and emission, using a high sensitivity. 
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Glucose Sensing 
The fluorescence of o-COOHBA, a novel BA sensor, has been compared to the 
fluorescence of m-MethoxyBA, a reported BA sensor, when studied in solution at pH 
7.4. Both BA sensors were shown to respond to glucose in the dynamic range of 
0-10mM, which corresponds to the ocular glucose concentration range in diabetics 
(~500µM – 5mM). 
Synthesis 
Successful synthesis of novel BA sensor o-COOHBA was confirmed by 
1H NMR. 
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Br o-COOHBA 0.5 mM was studied in pH buffers 
5.18, 7.4 and 9.44 with glucose, correlating to 
the ocular glucose concentrations. The change 
in fluorescence intensity was not seen below 
pH 6, due to the pKa of 6 for the fluorescent  
sugar-bound BA form. 
Fluorescent 
Non-Fluorescent 
Excitation wavelength 380 nm; Emission wavelength: 485 nm; Slit width 5 nm 
for excitation and 2.5 nm for emission, using a high sensitivity. 
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Introduction 
Diabetes is an incurable disease that promotes acute and chronic complications, namely blindness, heart disease or kidney failure. Monitoring the disease marker 
glucose in blood can prolong life expectancy by allowing diabetics to manage episodes of hypo- or hyperglycaemia. Currently, noninvasive-continuous monitoring 
systems are not commercially available. The use of boronic acids (BAs) for sensing sugars is well-known, as these Lewis acids have a high affinity for diol-containing 
compounds. Fluorescent BA derivatives have been investigated for potential use in sensing devices, such as smart contact lenses, as they have shown a decrease in 
fluorescent intensity on increased glucose concentrations. This novel sensing platform could provide personal management of ocular-glucose levels for diabetics via a 
noninvasive optical sensor, in contrast to the electrochemical approach employed by Google and Novartis. 
 
